Assessing Care Value for Older Patients Receiving Radiotherapy With or Without Cisplatin or Cetuximab for Locoregionally Advanced Head and Neck Cancer

IMPORTANCE: Clinicians frequently use radiotherapy with cetuximab over radiotherapy only or radiotherapy with cisplatin because of a perceived survival and tolerability advantage, but scant data are available to support this perception. OBJECTIVE: To measure the 3 aspects of value (quality, outcomes...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:JAMA Otolaryngol Head Neck Surg
Hlavní autoři: Saraswathula, Anirudh, Chen, Michelle M., Colevas, A. Dimitrios, Divi, Vasu
Médium: Artigo
Jazyk:Inglês
Vydáno: American Medical Association 2019
Témata:
Original Investigation
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6802372/
https://ncbi.nlm.nih.gov/pubmed/31621810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoto.2019.2381
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky